Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. S. (Steven) de Jong

Publicaties

Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo.

Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma

Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models

Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

NOTCH signaling limits the response of Low Grade Serous Ovarian Cancers to MEK inhibition

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities